Jasper Therapeutics
JSPR
JSPR
23 hedge funds and large institutions have $37.5M invested in Jasper Therapeutics in 2022 Q2 according to their latest regulatory filings, with 5 funds opening new positions, 9 increasing their positions, 3 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
less ownership
Funds ownership: →
4% less funds holding
Funds holding: 24 → 23 (-1)
17% less first-time investments, than exits
New positions opened: 5 | Existing positions closed: 6
46% less capital invested
Capital invested by funds: $69.6M → $37.5M (-$32.1M)
Holders
23
Holding in Top 10
3
Calls
$118K
Puts
$1K
Top Buyers
1 | +$93.6K | |
2 | +$77.9K | |
3 | +$32K | |
4 |
State Street
Boston,
Massachusetts
|
+$21.3K |
5 |
UBS Group
Zurich,
Switzerland
|
+$11K |
Top Sellers
1 | -$894K | |
2 | -$41.6K | |
3 | -$39K | |
4 |
VAFP
Vahanian & Associates Financial Planning
Saratoga Springs,
New York
|
-$36K |
5 |
HCM
Highbridge Capital Management
New York
|
-$3K |